Scientists show jet lag conditions impair immune response in mice

October 14, 2020

Imagine you've just arrived in Paris. Your body thinks it should be midnight - a restorative time when your cells typically proofread DNA, organize and store energy, and perform other essential chores - but, instead, the sun is up and you're awake. On a molecular level, your cells are stressed, trying to catch up to new environmental conditions.

Shiftwork and experimental models of frequent flying across time zones have been correlated with cancer risk, but not much is known about how these circadian disruptions impact the body's ability to curb cancer growth on a molecular scale.

Now, a new study published today (Wednesday, Oct. 14) in Science Advances reveals that chronic jet lag alters the microenvironment surrounding tumor cells, making it more favorable for tumor growth, and also hinders the body's natural immune defenses.

The research, led by corresponding authors Carla Finkielstein, an associate professor at the Fralin Biomedical Research Institute at VTC, and Diego Golombek, a professor at the National University of Quilmes in Argentina, adds to the rapidly growing scientific field of the effect of circadian disruption on health and wellbeing.

"A key takeaway from this study is that if someone has a proliferative disorder, in this case melanoma, doing shift work or regularly changing time zones could exacerbate the problem by dampening immune system response to tumor growth," said Finkielstein, who is also an associate professor of biology in Virginia Tech's College of Science, and director of the Molecular Diagnostics Laboratory at the Fralin Biomedical Research Institute. "This research also helps explain why some tumors win the race when a person is exposed to the chronically stressful conditions that occur when the environment and the body's clocks are misaligned."

Every cell in your body has its own set of molecular clocks - a series of genes, proteins, and signaling chemicals that set the pace for cell growth, division, and decay. In cancer cells, these clocks are often altered, which allows the tumor to set its own pace for rapid, unchecked proliferation.

The body's master timekeeper is located in the brain, where it's entrained by light and sends signals to synchronize peripheral clocks located throughout the body. When our perception of day and night becomes muddled due to irregular intervals of light and dark, our internal clocks and the environment are misaligned, which, as this study shows, can have subtle yet significant consequences at a cellular level.

The researchers wanted to know how chronic jet lag impacts the microenvironment surrounding cancer cells and examined two groups of mice that were injected with melanoma cells. The first group was exposed to a normal circadian schedule: 12 hours of light and 12 hours of dark. The second group's light and dark exposure was shifted by six hours every two days - the equivalent of roaming across 21 time zones per week.

A month later, the scientists observed that the tumors in the jet lagged group were roughly three times the size of the control group.

They also examined samples from the microenvironment surrounding the tumor, the spleen, which produces immune cells, and the liver. The researchers found peculiar contrasts in how the immune system responded to the tumor. For example, the levels of different types of immune cells called macrophages were inverted to be more prone to accept tumor growth in the jet lagged group.

Similarly, the rhythms of other immune cells and molecules, including cytokines, were disrupted. Even though the tumors didn't spread into their neighboring organ, the liver, or the spleen, the scientists observed that the circadian variations in the immune system in both of these organs were deregulated.

"We combined two different approaches of chronobiology research to study the effects of circadian desynchronization on both tumor growth and immune rhythms, and we found a link," Golombek said. "You need optimal rhythms in immune cells and immune humoral factors to quell rapid tumor growth. When circadian rhythms are chronically disrupted, these rhythms are impaired, inverted, or disappear entirely, which could help explain why the tumors were significantly larger in the desynchronized group."

Finkielstein and Golombek plan to continue studying how immune genes and cell cycle genes are related in the context of cancer.
-end-
This research, supported by the National Science Foundation in the United States and the National Science Agency in Argentina, represents an international collaboration between Finkielstein and Golombek's laboratories in Virginia and Buenos Aires, respectively. Over two years, the first author, Ignacio Aiello, a graduate student, worked in both laboratories. Aiello's doctoral mentor, Natalia Paladino, also contributed to the study.

Virginia Tech

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.